September 16, 2014 8:34 PM ET

Biotechnology

Company Overview of Predix Pharmaceuticals, Inc., prior to acquisition by Physiome Sciences, Inc.

Company Overview

As of August 12, 2003, Predix Pharmaceuticals, Inc. was acquired by Physiome Sciences, Inc. Predix Pharmaceuticals, Inc., a drug development company, engages in integrating computational and medicinal chemistry to create new drugs targeted to G-protein coupled receptors (GPCRs) and ion channels. Its product pipeline comprises PRX-00023 for anxiety, which has completed phase I trials; PRX-03140 for alzheimer's disease and other cognitive disorders, which is in phase I trials; and PRX-08066 for Pulmonary Hypertension. Predix Pharmaceuticals was co-founded by Silvia Noiman, Haim Aviv, Oren M. Becker, and Ramot in 2000. The company was formerly known as Bio-Information Technologies, Ltd. Predix ...

10K Gill Street

Woburn, MA 01801

United States

Founded in 2000

Phone:

781-376-0821

Fax:

781-376-0822

Key Executives for Predix Pharmaceuticals, Inc., prior to acquisition by Physiome Sciences, Inc.

Predix Pharmaceuticals, Inc., prior to acquisition by Physiome Sciences, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Integene International Holdings LLC United States
Medistem, Inc. United States
Lipella Pharmaceuticals, Inc. United States
MiPod Nuclear Inc. United States
ArmaGen Technologies, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Predix Pharmaceuticals, Inc., prior to acquisition by Physiome Sciences, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.